Measles testing is ramping up at University of Washington Medicine as the Puget Sound area gets ready to welcome a flood of out-of-state visitors this summer, potentially coinciding with a nationwide ...

Opportunities in the COVID-19 tests market include developing innovative products, leveraging global and regional trends, understanding competitive dynamics, and accessing country-specific regulatory ...

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, ...

Background Raised cardiac troponin-I is a common finding in patients hospitalised with acute viral infections, including but not limited to COVID-19. This often occurs in the absence of overt ...

Invivyd, Inc. (NASDAQ:IVVD) Q4 2025 Earnings Call Transcript March 5, 2026 Invivyd, Inc. misses on earnings expectations. Reported EPS is $-0.06428 EPS, expectations were $-0.06. Operator: Good day, ...

Achieved Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth quarter-over-quarter2025 year-end cash and cash equivalents of $226.

Researchers have discovered in a new research that COVID-19 infection is associated with an increased risk of a subsequent diagnosis of chronic rhinosinusitis (CRS). This suggests a possible ...

The COVID-19 pandemic brought the term "Polymerase Chain Reaction testing" into the mainstream. The PCR method is a type of ...

SARS-CoV-2 infection was also implicated in new-onset chronic kidney disease, acute kidney injury, and end-stage renal disease.

RSV was associated with 190,000 to 350,000 hospitalizations from July 1, 2024, to June 30, 2025, as well as 10,000 to 23,000 ...

The COVID-19 pandemic brought the term "Polymerase Chain Reaction testing" into the mainstream. The PCR method is a type of nucleic acid amplification ...

Bioxytran, Inc. (OTCQB:BIXT), a clinical-stage biotechnology company developing carbohydrate-based therapeutics, today ...